SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-049190
Filing Date
2023-10-23
Accepted
2023-10-23 16:58:24
Documents
13
Period of Report
2023-10-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20013008_8k.htm   iXBRL 8-K 39480
2 EXHIBIT 10.1 ef20013008_ex10-1.htm EX-10.1 51717
  Complete submission text file 0001140361-23-049190.txt   246406

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cycn-20231017.xsd EX-101.SCH 3868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20231017_lab.xml EX-101.LAB 23290
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20231017_pre.xml EX-101.PRE 16554
7 EXTRACTED XBRL INSTANCE DOCUMENT ef20013008_8k_htm.xml XML 4223
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 231340451
SIC: 2834 Pharmaceutical Preparations